
BrainCo is a technology company focused on brain-computer interface innovations that enable direct brain communication with digital devices. It creates cognitive training products for individuals, students, and those with neurological conditions, enhancing wellness and educational outcomes. The company combines expertise in neuroscience and machine learning to advance non-invasive brain technology applications.

BrainCo is a technology company focused on brain-computer interface innovations that enable direct brain communication with digital devices. It creates cognitive training products for individuals, students, and those with neurological conditions, enhancing wellness and educational outcomes. The company combines expertise in neuroscience and machine learning to advance non-invasive brain technology applications.
What they do: Develop non‑invasive brain–computer interface devices and cognitive‑training platforms for education and wellness
Founded: 2015
Founder / CEO: Bicheng Han (founder; was a Harvard Center for Brain Science PhD candidate at founding)
Headquarters (historical): Somerville, Massachusetts (company later relocated operations to Hangzhou, China per available records)
Known funding: USD 27,640,000 (total disclosed)
| Company |
|---|
Cognitive training, attention/focus enhancement, wellness, and educational technology using non‑invasive neurotechnology.
2015
Biotechnology Research
Round listed on Dealroom (March 2015 entry)
Round listed on Dealroom (December 2016 entry)
Round listed on Dealroom (March 2018 entry)
Series A announced Feb 25, 2020 (lead investor reported as Northern Star Partners)
Dealroom lists a January 2026 Series B with multiple named investors (investors listed on Dealroom include Walden International and IDG Capital among others)
“Investors include institutional backers (Northern Star Partners named as Series A lead) plus a mix of early angels/grant supporters and later‑stage investors (Dealroom and Crunchbase list investors such as Northern Star Partners, Walden International, IDG Capital, Wandai Capital, Hantan Capital, MassChallenge, Boston Angel Club, and Startupbootcamp Digital Health Chengdu).”
核心职责: 1. 干预方案标准化与智能化 SOP 搭建: 协助医学团队梳理针对代谢异常人群的生活方式干预标准作业程序。将晦涩的临床指南转化为用户易执行、可量化的每日行动清单。 AI 辅助探索: 参与探索如何利用 LLM (大语言模型) 工具优化患者管理流程。协助调试“自动化反馈话术”,提升受试者在依从性管理方面的体验与效率。 2.临床试验文档与伦理申报 医学文档撰写: 在指导下,协助撰写或完善临床试验的关键文档,包括但不限于《研究方案 (Protocol)》、《受试者知情同意书 (ICF)》及《研究者手册》。 伦理合规支持: 负责整理伦理委员会 (IRB) 申请所需的各项资料,确保文件符合 GCP (临床试验质量管理规范) 要求,协助推进伦理审批流程。 3.项目执行与数据协作 受试者管理: 协助临床协调员 (CRC) 进行受试者的招募筛选、入组宣教及随访排期管理。 数据整理: 负责临床数据的收集、录入与基础清洗(如饮食记录、身体指标数据的标准化),确保数据的真实性与完整性。 4.科研文件资料协助整理。 任职要求: 专业背景:临床医学、公共卫生(流行病/统计)、营养学、药学或相关专业,本科高年级或研究生在读。有医院营养科实习或参与过临床课题(IIT)经验者优先。有营养师注册者优先。 关键能力:1.医学逻辑强: 具备良好的医学文献检索与阅读能力(中英文),能快速提炼循证依据。 2.文笔严谨: 具备优秀的医学写作能力。 3.工具熟练: 熟练使用 Office 办公软件;对 ChatGPT / AI 工具有实际使用经验或浓厚兴趣,会用科技手段解决重复性工作。 综合素质:细致负责: 对临床伦理和数据质量有敬畏心,工作不浮躁。 沟通顺畅: 能与医学专家及受试者进行有效沟通。
职位薪资:
180-200/天
想要了解更多,可以访问公司官网:https://www.brainco.cn/#/